Walid F. Gellad, MD, MPH

July 15, 2019

Regardless of the number of manufacturers, generic drug prices presented double-digit average increases from 2012 to 2015.

May 26, 2017

Enrollees in Medicaid plans employing prior authorization policies for opioid medications may have lower rates of opioid medication abuse and overdose.

April 15, 2015

There were no significant differences in the risk of ambulatory care—sensitive condition hospitalization or mortality between patients who initiated analogue insulin compared with the neutral protamine Hagedorn.

March 14, 2014

From 2001 to 2011, the US Food and Drug Administration approved 9 single-enantiomer drugs with racemic precursors. None showed pre-approval evidence of improved efficacy over the racemic precursor.

September 14, 2012

High-risk drug use increased slightly among seniors gaining Medicare Part D coverage; however, high-risk drugs account for a small share of total drug use.

October 15, 2010

Substantial variation in prescription spending and use of brand-name drugs exists across the VA healthcare system, with no apparent relationship to quality of care.